L-phenylalanine selectively depresses currents at glutamatergic excitatory synapses

Journal of Neuroscience Research

Volumn 72, Issue 1, 2003, Pages 116-124

  Glushakov, A V ^a   Dennis, D M ^a,b   Sumners, C ^a,b   Seubert, C N ^a   Martynyuk, Anatoly E ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cerebrocortical neurons; Hippocampal neurons; L phenylalanine; MEPSCs; MlPSCs; NMDA receptor; Phenylketonuria

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BICUCULLINE; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLYCINE; GLYCINE RECEPTOR; LEUCINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENYLALANINE; STRYCHNINE; TETRODOTOXIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DYSFUNCTION; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MENTAL DEFICIENCY; MOUSE; NEWBORN; NONHUMAN; PATCH CLAMP; PHENYLKETONURIA; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; SYNAPTIC TRANSMISSION; TISSUE SPECIFICITY;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; MICE; NEURONS; PHENYLALANINE; RATS; RECEPTORS, GLUTAMATE; SYNAPSES;

EID: 0037381514     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10569     Document Type: Article

References (44)

1. Attwell PJ, Rahman S, Yeo CHJ. 2001. Acquisition of eyeblink conditioning is critically dependent on normal function in cerebellar cortical lobule HVI. Neuroscience 21:5715-5722.
2. Aubert M, Guiramand J, Croce A, Roch G, Szafarczyk A, Vignes M. 2001. An endogenous adrenoceptor ligand potentiates excitatory synaptic transmission in cultured hippocampal neurons. Cereb Cortex 11:878-887.
3. Bauman ML, Kemper TL. 1982. Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol 58:55-63.
4. Behr J, Gloveli T, Schmitz D, Heinemann U. 2000. Dopamine depresses excitatory synaptic transmission onto rat subicular neurons via presynaptic Dl-like dopamine receptors. J Neurophysiol 84:112-119.
5. Berger AJ, Dieudonne S, Ascher P. 1998. Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses. J Neurophysiol 80:3336-3340.
6. Bergeron R, Meyer TM, Coyle JT, Greene RW. 1998. Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc Natl Acad Sci USA 95:15730-15734.
7. Boehm S. 1999. Presynaptic alpha2-adrenoceptors control excitatory, but not inhibitory, transmission at rat hippocampal synapses. J Physiol 519:439-449.
8. Boehm S, Betz H. 1997. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. J Neurosci 17:4066-4075.
9. Borroni AM, Fichtenholtz H, Woodside BL, Teyler TJ. 2000. Role of voltage-dependent calcium channel long-term potentiation (LTP) and NMDA LTP in spatial memory. J Neurosci 20:9272-9276.
10. Chandler LJ, Sutton G, Norwood D, Sumners C, Crews FT. 1997. Chronic ethanol increases N-methyl-D-aspartate-stimulated nitric oxide formation but not receptor density in cultured cortical neurons. Mol Pharmacol 51:733-740.
11. Engert F, Bonhoeffer T. 1999. Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 399:66-70.
12. Fischer M, Kaech S, Wagner U, Brinkhaus H, Matus A. 2000. Glutamate receptors regulate actin-based plasticity in dendritic spines. Nat Neurosci 3:887-894.
13. Glushakov AV, Dennis DM, Morey TE, Sumners C, Cucchiara RF, Seubert CN, Martynyuk AE. 2002. Specific inhibition of N-methyl-D-aspartate receptor function in rat hippocampal neurons by L-phenylalanine at concentrations observed during phenylketonuria. Mol Psychiatry 7:359-367.
14. Grunwald T, Beck H, Lehnertz K, Blumcke I, Pezer N, Kurthen M, Fernandez G, Van Roost D, Heinze HJ, Kutas M, Elger CE. 1999. Evidence relating human verbal memory to hippocampal N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 96:12085-12089.
15. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100.
16. Hsieh MC, Berry HK. 1979. Distribution of phenylalanine hydroxylase (EC 1.14.3.1) in liver and kidney of vertebrates. J Exp Zool 208:161-167.
17. Huttenlocher PR. 2000. The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr 159(Suppl 2):S102-S106.
18. Loy R, Koziell DA, Lindsey JD, Moore RY. 1980. Noradrenergic innervation of the adult rat hippocampal formation. J Comp Neurol 189:699-710.
19. Kaufman S. 1989. An evaluation of the possible neurotoxicity of metabolites of phenylalanine. J Pediatr 114:895-900.
20. Koch R, Hanley W, Levy H, Matalon R, Rouse B, Dela Cruz F, Azen C, Gross Friedman E. 1990. A preliminary report of the collaborative study of maternal phenylketonuria in the United States and Canada. J Inherit Metab Dis 13:641-650.
21. Maletic-Savatic M, Malinow R, Svoboda K. 1999. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science 283:1923-1927.
22. McAllister AK, Stevens CF. 2000. Nonsaturation of AMPA and NMDA receptors at hippocampal synapses. Proc Natl Acad Sci USA 97:6173-6178.
23. McKean CM. 1972. The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain. Brain Res 47:469-476.
24. McKinney RA, Capogna M, Durr R, Gahwiler BH, Thompson SM. 1999. Miniature synaptic events maintain dendritic spines via AMPA receptor activation. Nat Neurosci 2:44-49.
25. Moller HE, Weglage J, Wiedermann D, Vermathen P, Bick U, Ullrich K. 1997. Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo. Brain Res 778:329-337.
26. Novotny EJ Jr, Avison MJ, Herschkowitz N, Petroff OA, Prichard JW, Seashore MR, Rothman DL. 1995. In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy. Pediatr Res 37:244-249.
27. 3H]glutamate binding sites in rat brain synaptic membranes. Brain Res 520:351-353.
28. Pare D, Lebel E, Lang EJ. 1997. Differential impact of miniature synaptic potentials on the soma and dendrites of pyramidal neurons in vivo. J Neurophysiol 78:1735-1739.
29. Pestronk A, Drachman DB, Griffin JW. 1976. Effect of botulinum toxin on trophic regulation of acetylcholine receptors. Nature 264:787-789.
30. Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, Bremer HJ. 1999. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 103:1169-1178.
31. Poser CM, Van Bogaert L. 1959. Neuropathologic observations in phenylketonuria. Brain 82:1-9.
32. Rupp A, Kreis R, Zschocke J, Slotboom J, Boesch C, Rating D, Pietz J. 2001. Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria. J Cereb Blood Flow Metab 21:276-284.
33. Rondi-Reig L, Libbey M, Eichenbaum H, Tonegawa S. 2001. CA1-specific N-methyl-D-aspartate receptor knockout mice are deficient in solving a nonspatial transverse patterning task. Proc Natl Acad Sci USA 98:3543-3548.
34. Saitoe M, Schwarz TL, Umbach JA, Gundersen CB, Kidokoro Y. 2001. Absence of junctional glutamate receptor clusters in Drosophila mutants lacking spontaneous transmitter release. Science 293:514-517.
35. 2+ channels involved? Neuropharmacology 34:1549-1557.
36. Scriver CR, Kaufman S. 2001. The hyperphenylalanenemia: phenylalanine hydroxylase deficiency. In: Scriver CR, William SS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. p 1667-1724.
37. Scholz KP, Miller RJ. 1992. Inhibition of quantal transmitter release in the absence of calcium influx by a G protein-linked adenosine receptor at hippocampal synapses. Neuron 8:1139-1150.
38. Siddiqui AH, Pilcher WH, Joseph SA. 1995. Tyrosine hydroxylase immunoreactive cells in the rat neocortex and hippocampus. Soc Neurosci Abstr 21:1134.
39. Smith I, Glossop J, Beasley M. 1990. Fetal damage due to maternal phenylketonuria: effects of dietary treatment and maternal phenylalanine concentrations around the time of conception. J Inherit Metab Dis 13:651-657.
40. Supplisson S, Bergman C. 1997. Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes. J Neurosci 17:4580-4590.
41. Surtees R, Blau N. 2000. The neurochemistry of phenylketonuria. Eur J Pediatr 159(Suppl 2):S109-S113.
42. Toni N, Buchs PA, Nikonenko I, Bron CR, Muller D. 1999. LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature 402:421-425.
43. Wilson MA, McNaughton BL. 1994. Reactivation of hippocampal ensemble memories during sleep. Science 265:676-679.
44. Zhu ZQ, Armstrong DL, Grossman RG, Hamilton WJ. 1990. Tyrosine hydroxylase-immunoreactive neurons in the temporal lobe in complex partial seizures. Ann Neurol 27:564-572.